Bristol Myers Squibb Company

Director Translational Medicine (MD) Hematology and Oncology

Location
San Francisco, CA, United States
Posted
Sep 03, 2020
Ref
R1521324
Required Education
Doctorate/PHD/MD
Position Type
Full time
Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.

Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.

We are looking to add another MD to our team of physicians based in San Francisco, CA

Responsibilities for this position include, but are not limited to, the following:
  • Translational Development Functions:  Part of the TD Leadership team responsible for defining and positioning the early oncology portfolio in collaboration with VP, Translational Development and colleagues in research, clinical development, and marketing
  • Medical lead for clinical trials in hematology and oncology from Candidate Nomination (pre-IND) through Proof-of-Concept including:  Articulating the clinical development strategy  Design, implementation and analysis of early stage clinical trials  Clinical leadership on cross-functional Early Development project teams
  • Close liaison with Translational Development Scientists, Discovery and Development Teams for defining Clinical PD or Biomarker assays.
  • Responsible for clinical drug safety monitoring and management, in conjunction with the drug safety physician.
  • Ad Hoc member of the Candidate Development Committee, that evaluates all IND candidates and Early Development programs.
  • Key resource for disease area expertise for the TD team.
  • Liaise with clinical and laboratory-based academic investigators in Early Oncology and be a focal point for defining and establishing relationships with key Global Phase 1 Centers.
  • Part of the team responsible for establishing key alliances with academic centers, co-operative groups, vendors and government agencies for cost effective implementation of Celgene's R&D and early development strategy.
  • Participate in formulating disease area strategy for target selection and validation.
  • Provide support to Business Development and the established teams, for potential in-licensing opportunities that may include potential therapeutics, emerging technologies, processes or capabilities that will enhance our Drug Discovery and Early Development efforts.


Skills/Knowledge Required:
  • MD or M.D./PhD,
  • MD is required.
  • 3 years relevant experience in translational research/Phase 1 clinical trials (e.g., IND submittals, Proof-of-Concept studies, first-in-patient studies, adaptive design studies, biomarker development, companion diagnostics, mechanism of action studies). Industry experience preferred but not required. Subspecialty board certification in hematology/oncology preferred.
  • Experience in leading innovative efforts to deploy technologies and assays for enhanced translational capabilities.
  • Superior leadership, management and organizational skills, and a reputation as an open, available and transparent communicator.
  • Science and patient driven.
  • Ability to interact effectively across boundaries using influencing and relationship building skills.
  • Ability to function at the interface of both the Discovery and Development teams, with the aim of providing the successful implementation of stratification strategies, clinical biomarker and pharmacodynamic assays in the early clinical studies.
  • Competence in analysis and solving of problems, and the ability to prioritize and make tradeoffs to achieve goals.
  • Domestic and international travel is expected as required.


Prerequisites:
  • Advanced degree(s) in relevant field (Hematology, Oncology): MD or MD/PhD. .
  • 3 years relevant experience in translational research/Phase 1 clinical trials (e.g., IND submittals, Proof-of-Concept studies, first-in-patient studies, adaptive design studies, biomarker development, companion diagnostics, mechanism of action studies). Industry experience preferred but not required. Subspecialty board certification in hematology/oncology preferred. MD is required.
  • MD required.


Bristol-Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees the resources to pursue their goals, both at work and in their personal lives.